Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
LifeTech Scientific Corporation（1302.HK） Announces 2021 Annual Results 2022-03-31 03:27
Symbiance announces the launch of SimpleStats, an application for statistical analysis and reporting of clinical data 2022-03-30 21:00
GenScript Receives "Best Contract Development and Manufacturing Organization Award" For the Third Time in a Row 2022-03-30 17:30
BioVaxys Expands Cancer Vaccine Platform 2022-03-30 16:02
Qiming's Portfolio Company Rendu Biotechnology Lists on STAR Market 2022-03-30 10:22
Antengene Announces IND Approval in China for a Phase II Study of Eltanexor (ATG-016) in Patients with High-Risk Myelodysplastic Syndromes 2022-03-30 09:00
RNAimmune Secures $27 Million Series A Round of Financing for Development of mRNA Therapeutics and Vaccines 2022-03-30 08:31
Brii Bio Announces Strategic Partnership with Sinopharm to Advance Commercialization of Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China 2022-03-30 08:05
Biosion licenses BSI-060T (anti-Siglec-15) to Pyxis Oncology 2022-03-29 23:00
CellOrigin Closed a New Round of Investment to Jump-start its iPSC Immune Cell Therapy Products Toward Clinics 2022-03-29 20:50
Laekna Therapeutics Appoints Jeff Porter, Ph.D. as Chairman of Scientific Advisory Board 2022-03-29 20:00
New Video Series "PSMA PET/CT TODAY" Discusses the Future of Prostate Cancer Care with Leading Experts 2022-03-29 19:00
Samsung Biologics holds 11th Annual General Meeting of Shareholders 2022-03-29 09:42
Daewoong Pharmaceutical submitted NDA for its global new drug Fexuclue Tablets to the Philippines 2022-03-29 09:00
ILC Dover Announces Liquid Single-Use Bioprocessing Bags for Rapidly Growing Biotherapeutics and Cell & Gene Therapy Markets 2022-03-29 05:11
Viva Biotech Announced 2021 Annual Results: Revenue Increased by 201.9% YoY, CRO Business Revenue Maintained Rapid Growth with an Increase of 68.7% 2022-03-29 01:01
Viva Biotech Announced 2021 Annual Results: Revenue Increased by 201.9% YoY, CRO Business Revenue Maintained Rapid Growth with an Increase of 68.7% 2022-03-29 00:49
Clarity's US-based Cu-64 SAR-bisPSMA trial in prostate cancer opens for recruitment 2022-03-28 21:06
At the 2022 AAD Annual Meeting, Senhwa Presents Positive Initial Data from Clinical Trial of Silmitasertib Used to Treat Patients with Advanced Basal Cell Carcinoma 2022-03-28 19:00
Vela Diagnostics Launches Focused (60 Genes) and Comprehensive (525 Genes) NGS-Based Pan-Cancer Panels 2022-03-28 15:00
1 185 186 187 188 189 453